NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

動物生物技術市場研究報告:按產品分類,按應用分類2025年預測-COVID-19的累積影響

Animal Biotechnology Market Research Report by Product, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 989556
出版日期 內容資訊 英文 189 Pages
商品交期: 最快1-2個工作天內
價格
動物生物技術市場研究報告:按產品分類,按應用分類2025年預測-COVID-19的累積影響 Animal Biotechnology Market Research Report by Product, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 189 Pages
簡介

2020年,全球動物生物技術市場規模為22654.79百萬美元/198.645億歐元。到2025年底,市場規模預計將達到32421.49百萬美元/28,427,770,000歐元。

COVID-19是前所未有的全球公共衛生突發事件,已影響到每個行業。這種長期影響預計將在預測期內影響行業增長。我們正在進行的研究正在擴大我們的研究範圍,以確保我們解決潛在的COVID-19問題和未來路徑。該報告提供了對COVID-19的見解,並考慮了消費者行為和需求,購買模式,供應鏈改路,當前市場趨勢以及政府的主要干預措施的變化。

該報告調查了動物生物技術市場,並概述了市場以及產品,應用和區域趨勢,COVID-19的累積影響以及進入該市場的公司的概況。

目錄

第1章簡介

  • 調查目的
  • 市場細分和範圍
  • 調查目標年度
  • 貨幣和價格
  • 語言
  • 限制
  • 利益相關者

第2章調查方法

  • 調查過程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:測量設備
    • 集合:數據源
    • 分析:數據解釋
    • 公式:數據驗證
    • 發佈:調查報告
    • 重複:報告更新
  • 進行調查
    • 開始:調查過程
    • 計劃:調查計劃
    • 執行:調查實施
    • 驗證:發現和分析
    • 出版物:調查報告
  • 調查結果

第3章執行摘要

  • 簡介
  • 市場前景
  • 展望的類型
  • 按產品類型劃分的展望
  • 最終用途行業展望
  • 區域展望
  • 競爭對手的展望

第4章市場概述

  • 簡介
  • COVID-19的累積效果
  • 地域增長機會

第5章市場洞察

  • 市場動態
    • 促進因素
    • 抑制因素
    • 市場機會
    • 挑戰
  • 波特五力分析
    • 新進入者的威脅
    • 替代威脅
    • 客戶的議價能力
    • 供應商的談判能力
    • 行業競爭

第6章按產品分列的全球動物生物技術市場

  • 簡介
  • 診斷測試
  • 毒品
  • 生殖/遺傳產品
  • 疫苗

第7章,按應用分列的全球動物生物技術市場

  • 簡介
  • 獸藥開發
  • 食品安全與藥品開發
  • 動物預防保健

第8章美洲動物生物技術市場

  • 簡介
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區動物生物技術市場

  • 簡介
  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第10章歐洲,中東和非洲的動物生物技術市場

  • 簡介
  • 法國
  • 德國
  • 意大利
  • 荷蘭
  • 卡塔爾
  • 俄羅斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合酋長國
  • 英國

第11章競爭情況

  • FPNV定位矩陣
    • 象限
    • 經營策略
    • 產品滿意度
  • 市場排名分析
  • 市場份額分析
  • 競爭性SWOT分析
  • 競爭情景
    • 併購
    • 協議,合作和夥伴關係
    • 推出和增強新產品
    • 投融資
    • 獎項,獎項,擴展

第12章企業可用性簡介

  • Abbott Laboratories
  • Bayer AG
  • Biogenesis Bago
  • Boehringer Ingelheim GmbH
  • Elanco
  • Genus plc
  • Ivaoes, LLC
  • Merck & Co., Inc.,
  • Merial
  • Neogen Corporation
  • Novartis
  • Pfizer, Inc.
  • Sanofi
  • Santa Cruz Biotechnology, Inc.
  • SCYNEXIS, Inc.
  • Trans Ova Genetics
  • VetDC, Inc.
  • Virbac Inc.
  • Z-Link Biotech
  • Zoetis Inc.

第13章附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-437517DB6EB7

The Global Animal Biotechnology Market size was estimated at USD 22.65 Billion in 2020 and expected to reach USD 24.45 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 8.27% to reach USD 36.49 Billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Animal Biotechnology to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Animal Biotechnology Market was studied across Diagnostic Tests, Drugs, Reporductive & Genetic Produtcs, and Vaccines.

Based on Application, the Animal Biotechnology Market was studied across Development of Animal Pharmaceuticals, Food Safety and Drug Development, and Preventive Care for Animals.

Based on Geography, the Animal Biotechnology Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Animal Biotechnology Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Animal Biotechnology Market, including Abbott Laboratories, Bayer AG, Biogenesis Bago, Boehringer Ingelheim GmbH, Elanco, Genus plc, Ivaoes, LLC, Merck & Co., Inc.,, Merial, Neogen Corporation, Novartis, Pfizer, Inc., Sanofi, Santa Cruz Biotechnology, Inc., SCYNEXIS, Inc., Trans Ova Genetics, VetDC, Inc., Virbac Inc., Z-Link Biotech, and Zoetis Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Animal Biotechnology Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Animal Biotechnology Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Animal Biotechnology Market?
  • 4. What is the competitive strategic window for opportunities in the Global Animal Biotechnology Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Animal Biotechnology Market?
  • 6. What is the market share of the leading vendors in the Global Animal Biotechnology Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Animal Biotechnology Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Product Outlook
  • 3.4. Application Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising focus toward cloning and transgenic animals
      • 5.1.1.2. Increasing R&D by major players
      • 5.1.1.3. Rising popularity and acceptance coupled with the regulatory approvals
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with R&D
      • 5.1.2.2. Ethical issues associated with the animal biotechnology products
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing animal meat consumption and the rising per capita animal healthcare expenditure
      • 5.1.3.2. Transgenic livestock for agriculture
    • 5.1.4. Challenges
      • 5.1.4.1. Potential negative impacts on animal welfare throughout the process
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Animal Biotechnology Market, by Product

  • 6.1. Introduction
  • 6.2. Diagnostic Tests
  • 6.3. Drugs
  • 6.4. Reporductive & Genetic Produtcs
  • 6.5. Vaccines

7. Animal Biotechnology Market, by Application

  • 7.1. Introduction
  • 7.2. Development of Animal Pharmaceuticals
  • 7.3. Food Safety and Drug Development
  • 7.4. Preventive Care for Animals

8. Americas Animal Biotechnology Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific Animal Biotechnology Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa Animal Biotechnology Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Abbott Laboratories
  • 12.2. Bayer AG
  • 12.3. Biogenesis Bago
  • 12.4. Boehringer Ingelheim GmbH
  • 12.5. Elanco
  • 12.6. Genus plc
  • 12.7. Ivaoes, LLC
  • 12.8. Merck & Co., Inc.,
  • 12.9. Merial
  • 12.10. Neogen Corporation
  • 12.11. Novartis
  • 12.12. Pfizer, Inc.
  • 12.13. Sanofi
  • 12.14. Santa Cruz Biotechnology, Inc.
  • 12.15. SCYNEXIS, Inc.
  • 12.16. Trans Ova Genetics
  • 12.17. VetDC, Inc.
  • 12.18. Virbac Inc.
  • 12.19. Z-Link Biotech
  • 12.20. Zoetis Inc.

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 2. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2020 (USD BILLION)
  • FIGURE 3. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2020 (USD BILLION)
  • FIGURE 4. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
  • FIGURE 5. GLOBAL ANIMAL BIOTECHNOLOGY MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL ANIMAL BIOTECHNOLOGY MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD BILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2026
  • FIGURE 10. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTIC TESTS, 2018-2026 (USD BILLION)
  • FIGURE 11. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTIC TESTS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 12. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUGS, 2018-2026 (USD BILLION)
  • FIGURE 13. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUGS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 14. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REPORDUCTIVE & GENETIC PRODUTCS, 2018-2026 (USD BILLION)
  • FIGURE 15. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REPORDUCTIVE & GENETIC PRODUTCS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 16. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2026 (USD BILLION)
  • FIGURE 17. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 18. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 19. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD BILLION)
  • FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 21. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DEVELOPMENT OF ANIMAL PHARMACEUTICALS, 2018-2026 (USD BILLION)
  • FIGURE 22. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DEVELOPMENT OF ANIMAL PHARMACEUTICALS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 23. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FOOD SAFETY AND DRUG DEVELOPMENT, 2018-2026 (USD BILLION)
  • FIGURE 24. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FOOD SAFETY AND DRUG DEVELOPMENT, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 25. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PREVENTIVE CARE FOR ANIMALS, 2018-2026 (USD BILLION)
  • FIGURE 26. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PREVENTIVE CARE FOR ANIMALS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 27. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 28. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 30. ARGENTINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 31. BRAZIL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 32. CANADA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 33. MEXICO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 34. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 35. CALIFORNIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 36. FLORIDA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 37. ILLINOIS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 38. NEW YORK ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 39. OHIO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 40. PENNSYLVANIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 41. TEXAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 42. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 43. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 44. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 45. CHINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 46. INDIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 47. INDONESIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 48. JAPAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 49. MALAYSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 50. PHILIPPINES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 51. SOUTH KOREA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 52. THAILAND ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 53. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 54. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 55. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 56. FRANCE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 57. GERMANY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 58. ITALY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 59. NETHERLANDS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 60. QATAR ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 61. RUSSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 62. SAUDI ARABIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 63. SOUTH AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 64. SPAIN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 65. UNITED ARAB EMIRATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 66. UNITED KINGDOM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 67. GLOBAL ANIMAL BIOTECHNOLOGY MARKET: FPNV POSITIONING MATRIX
  • FIGURE 68. GLOBAL ANIMAL BIOTECHNOLOGY MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 69. GLOBAL ANIMAL BIOTECHNOLOGY MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 70. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANIMAL BIOTECHNOLOGY MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL ANIMAL BIOTECHNOLOGY MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 4. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTIC TESTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 5. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUGS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 6. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REPORDUCTIVE & GENETIC PRODUTCS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 7. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 8. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 9. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DEVELOPMENT OF ANIMAL PHARMACEUTICALS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 10. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FOOD SAFETY AND DRUG DEVELOPMENT, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 11. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PREVENTIVE CARE FOR ANIMALS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 12. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 13. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 14. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 15. ARGENTINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 16. ARGENTINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 17. BRAZIL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 18. BRAZIL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 19. CANADA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 20. CANADA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 21. MEXICO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 22. MEXICO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 23. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 24. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 25. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 26. CALIFORNIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 27. CALIFORNIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 28. FLORIDA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 29. FLORIDA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 30. ILLINOIS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 31. ILLINOIS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 32. NEW YORK ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 33. NEW YORK ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 34. OHIO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 35. OHIO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 36. PENNSYLVANIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 37. PENNSYLVANIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 38. TEXAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 39. TEXAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 40. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 41. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 42. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 43. CHINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 44. CHINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 45. INDIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 46. INDIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 47. INDONESIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 48. INDONESIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 49. JAPAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 50. JAPAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 51. MALAYSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 52. MALAYSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 53. PHILIPPINES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 54. PHILIPPINES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 55. SOUTH KOREA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 56. SOUTH KOREA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 57. THAILAND ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 58. THAILAND ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 62. FRANCE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 63. FRANCE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 64. GERMANY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 65. GERMANY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 66. ITALY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 67. ITALY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 68. NETHERLANDS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 69. NETHERLANDS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 70. QATAR ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 71. QATAR ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 72. RUSSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 73. RUSSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 74. SAUDI ARABIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 75. SAUDI ARABIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 76. SOUTH AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 77. SOUTH AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 78. SPAIN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 79. SPAIN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 80. UNITED ARAB EMIRATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 81. UNITED ARAB EMIRATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 82. UNITED KINGDOM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 83. UNITED KINGDOM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 84. GLOBAL ANIMAL BIOTECHNOLOGY MARKET: SCORES
  • TABLE 85. GLOBAL ANIMAL BIOTECHNOLOGY MARKET: BUSINESS STRATEGY
  • TABLE 86. GLOBAL ANIMAL BIOTECHNOLOGY MARKET: PRODUCT SATISFACTION
  • TABLE 87. GLOBAL ANIMAL BIOTECHNOLOGY MARKET: RANKING
  • TABLE 88. GLOBAL ANIMAL BIOTECHNOLOGY MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 89. GLOBAL ANIMAL BIOTECHNOLOGY MARKET: SHARE, BY COMPANY, 2020
  • TABLE 90. GLOBAL ANIMAL BIOTECHNOLOGY MARKET: MERGER & ACQUISITION
  • TABLE 91. GLOBAL ANIMAL BIOTECHNOLOGY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 92. GLOBAL ANIMAL BIOTECHNOLOGY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 93. GLOBAL ANIMAL BIOTECHNOLOGY MARKET: INVESTMENT & FUNDING
  • TABLE 94. GLOBAL ANIMAL BIOTECHNOLOGY MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 95. GLOBAL ANIMAL BIOTECHNOLOGY MARKET: LICENSE & PRICING
  • TABLE 96. GLOBAL ANIMAL BIOTECHNOLOGY MARKET: CONTACT DETAILS